Results for pharmaceuticals: 2542

BRUSSELS, Dec 9 - European Union antitrust authorities said on Wednesday they had raided several pharmaceutical companies in a number of EU member states on suspicion of abusing a dominant position in the market. The...

Shenzhen-listed Guangzhou Baiyunshan Pharmaceutical Co Ltd<000522> said yesterday it would halt share trading starting today after shares surged daily limit on Wednesday and Thursday, sources reported. The company said in a statement filed with the Shenzhen Stock Exchange that it expects to disclose...

Shanghai Fosun Pharmaceutical (Group) Co Ltd<600196> recently raised its shareholding in Tongjitang Chinese Medicines Co (Tongjitang)<TCM> to 20.02%, according to a statement Shanghai Fosun Pharmaceutical filed with the Shanghai Stock Exchange....

GlaxoSmithKline and Idenix Pharmaceuticals, Inc. announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899...

King Pharmaceuticals said Monday that it had agreed to acquire Alpharma for about $1.6 billion, expanding King's presence in the market for pain drugs ...

a multi-specialty healthcare company, and Spectrum Pharmaceuticals, a biopharmaceutical company, have signed an exclusive collaborative agreement for the development and commercialisation of apaziquone, an anti-neoplastic agent currently being investigated for the treatment of...

Nov. 11, 2008 (China Knowledge) - Tibet Rhodiola Pharmaceutical Holding Company<600211> has inked agreement with Hong Kong-listed Core Healthcare Investment<8250> to cancel the plan of establishing a joint venture (JV), sources reported. A...

There will be major changes in the global pharmaceutical market and key changes in the top ten company list by 2012, says a new report from URCH Publishing, provider of pharmaceutical industry business information...

Nov. 10, 2008 (China Knowledge) - Harbin Pharmaceutical Group Co Ltd<600664>, China's second-biggest drug maker by market value, Monday announced it would issue RMB 800 million financing bonds with a maturity of 365 days on...

GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International have announced their worldwide collaboration agreement for the investigational drug Retigabine, a neuronal potassium channel opener for treatment of adult epilepsy...